Woodline Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2M Hold
164,305
0.08% 324
2025
Q4
$23.4M Hold
164,305
0.09% 278
2025
Q3
$19.7M Hold
164,305
0.09% 288
2025
Q2
$21.7M Buy
164,305
+3,395
+2% +$460K 0.11% 267
2025
Q1
$22.3M Buy
160,910
+38,671
+32% +$6M 0.15% 208
2024
Q4
$19M Buy
122,239
+5,300
+5% +$896K 0.13% 217
2024
Q3
$21.3M Sell
116,939
-66,369
-36% -$9.83M 0.18% 184
2024
Q2
$21.8M Buy
183,308
+109,801
+149% +$11.6M 0.21% 155
2024
Q1
$7.89M Buy
+73,507
New +$7.31M 0.07% 302
2023
Q4
Sell
-49,631
Closed -$5.91M 561
2023
Q3
$5.91M Sell
49,631
-43,104
-46% -$6.43M 0.07% 297
2023
Q2
$16.5M Buy
92,735
+23,953
+35% +$4.39M 0.2% 150
2023
Q1
$11.3M Sell
68,782
-30,887
-31% -$5.31M 0.15% 180
2022
Q4
$15.7M Buy
99,669
+18,056
+22% +$2.75M 0.21% 141
2022
Q3
$12.3M Buy
81,613
+74,333
+1,021% +$12.4M 0.17% 173
2022
Q2
$1.2M Sell
7,280
-38,087
-84% -$7.33M 0.02% 499
2022
Q1
$10.1M Sell
45,367
-68,748
-60% -$15.4M 0.16% 173
2021
Q4
$27.1M Buy
114,115
+43,504
+62% +$10.2M 0.39% 59
2021
Q3
$16.5M Buy
70,611
+24,419
+53% +$5.12M 0.27% 104
2021
Q2
$9.51M Sell
46,192
-32,283
-41% -$6.64M 0.18% 141
2021
Q1
$16.1M Buy
78,475
+9,216
+13% +$1.95M 0.36% 80
2020
Q4
$14.9M Sell
69,259
-23,004
-25% -$4.46M 0.39% 79
2020
Q3
$16.9M Sell
92,263
-35,462
-28% -$6.68M 0.55% 48
2020
Q2
$23.5M Buy
127,725
+69,822
+121% +$13.9M 0.93% 36
2020
Q1
$11.7M Sell
57,903
-4,668
-7% -$899K 0.83% 36
2019
Q4
$11.7M Buy
+62,571
New +$10.8M 0.48% 67

Other funds holding ICUI

Woodline Partners's ICUI Position: Q1 2026 in Review

Woodline Partners held its ICU Medical (ICUI) position steady in Q1 2026 at 164,305 shares worth $21.2M. The position accounts for 0.08% of the portfolio, ranked #324.

Woodline Partners first reported a position in ICUI in Q4 2019 and has held it in 25 quarters since. The position peaked at $27.1M in Q4 2021. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Woodline Partners held 164,305 shares of ICU Medical worth $21.2M as of Q1 2026.
  • Woodline Partners left its ICU Medical share count unchanged in Q1 2026.
  • ICU Medical made up 0.08% of Woodline Partners's portfolio in Q1 2026, its #324 holding.
  • Woodline Partners first reported a position in ICU Medical in Q4 2019 and has held it in 25 quarters since.
  • Woodline Partners's ICU Medical position peaked at $27.1M in Q4 2021.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.